STX-100 is a humanized antibody targeting integrin alphavbeta6 (ITGAV & ITGB6) with anti-tumor activity, inhibits pSMAD2, inhibits the conversion of fibroblasts to myofibroblasts, and can be used to study idiopathic pulmonary fibrosis (IPF).
Purity:
97.50%
Target:
Integrin
* VAT and and shipping costs not included. Errors and price changes excepted